DK613889D0 - Farmaceutisk praeparat indeholdende 1-isobutyl-1h-imidazo(4,5-c)quinolin-4-amin - Google Patents

Farmaceutisk praeparat indeholdende 1-isobutyl-1h-imidazo(4,5-c)quinolin-4-amin

Info

Publication number
DK613889D0
DK613889D0 DK613889A DK613889A DK613889D0 DK 613889 D0 DK613889 D0 DK 613889D0 DK 613889 A DK613889 A DK 613889A DK 613889 A DK613889 A DK 613889A DK 613889 D0 DK613889 D0 DK 613889D0
Authority
DK
Denmark
Prior art keywords
quinolin
imidazo
isobutyl
amine
pharmaceutical preparation
Prior art date
Application number
DK613889A
Other languages
English (en)
Other versions
DK176121B1 (da
DK613889A (da
Inventor
Steven Marshall Wick
Helen Jensen Schultz
Gregory Roy Nelson
Amit Kumar Mitra
Stephen Michael Berge
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of DK613889D0 publication Critical patent/DK613889D0/da
Publication of DK613889A publication Critical patent/DK613889A/da
Application granted granted Critical
Publication of DK176121B1 publication Critical patent/DK176121B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK198906138A 1988-12-15 1989-12-06 Farmaceutisk præparat indeholdende 1-isobutyl-1H-imidazol[4,5-c]-quinolin-4-amin DK176121B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28493388A 1988-12-15 1988-12-15
US28493388 1988-12-15

Publications (3)

Publication Number Publication Date
DK613889D0 true DK613889D0 (da) 1989-12-06
DK613889A DK613889A (da) 1990-06-16
DK176121B1 DK176121B1 (da) 2006-09-11

Family

ID=23092090

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198906138A DK176121B1 (da) 1988-12-15 1989-12-06 Farmaceutisk præparat indeholdende 1-isobutyl-1H-imidazol[4,5-c]-quinolin-4-amin

Country Status (13)

Country Link
EP (1) EP0376534B1 (da)
JP (1) JP2915034B2 (da)
KR (1) KR0150445B1 (da)
AU (1) AU631585B2 (da)
CA (1) CA2004597C (da)
DE (2) DE19975026I2 (da)
DK (1) DK176121B1 (da)
ES (1) ES2062043T3 (da)
IE (1) IE62569B1 (da)
IL (1) IL92537A (da)
NL (1) NL980042I1 (da)
NZ (1) NZ231655A (da)
ZA (1) ZA899450B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ232740A (en) * 1989-04-20 1992-06-25 Riker Laboratories Inc Solution for parenteral administration comprising a 1h-imidazo(4,5-c) quinolin-4-amine derivative, an acid and a tonicity adjuster
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
CN1128955A (zh) * 1993-08-10 1996-08-14 藤泽药品工业株式会社 经皮吸收制剂
DE4434775A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Dermatologische Zubereitungen mit einem Gehalt an Fettsäureglyceriden gegen Superinfektionen
US5939090A (en) * 1996-12-03 1999-08-17 3M Innovative Properties Company Gel formulations for topical drug delivery
IT1294748B1 (it) * 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
US6245776B1 (en) * 1999-01-08 2001-06-12 3M Innovative Properties Company Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
WO2002092070A1 (en) * 2001-05-11 2002-11-21 Elan Corporation, Plc Isostearic acid salts as permeation enhancers
WO2002092616A1 (en) 2001-05-11 2002-11-21 Orasense, Ltd. Antisense permeation enhancers
CN1292751C (zh) * 2002-04-23 2007-01-03 四川大学 皮肤局部用咪喹莫特或其衍生物脂质体及其制备方法和用途
NZ567227A (en) * 2003-03-13 2010-01-29 3M Innovative Properties Co Methods of improving skin quality through topical application of an immune response modifier such as imiquimod
ES2426445T3 (es) 2006-04-07 2013-10-23 Merrion Research Iii Limited Forma de dosificación oral sólida que contiene un potenciador
WO2008008397A2 (en) 2006-07-14 2008-01-17 Stiefel Research Australia Pty Ltd Fatty acid pharmaceutical foam
AU2007275815A1 (en) * 2006-07-18 2008-01-24 Wirra Ip Pty. Ltd. Immune response modifier formulations
WO2009137080A1 (en) 2008-05-07 2009-11-12 Merrion Research Iii Limited Compositions of gnrh related compounds and processes of preparation
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
US8802114B2 (en) 2011-01-07 2014-08-12 Merrion Research Iii Limited Pharmaceutical compositions of iron for oral administration
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤
ES2940736B2 (es) 2021-11-09 2023-09-19 Ntd Labs S L U Uso combinado de imiquimod y de un hidrolizado de caseina para el tratamiento de condilomas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73534A (en) * 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
ATE77962T1 (de) * 1985-02-25 1992-07-15 Univ Rutgers Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen.
CA1288698C (en) * 1985-08-30 1991-09-10 Rutgers, The State University Of New Jersey Transdermal anti-anginal pharmaceutical dosage

Also Published As

Publication number Publication date
IL92537A (en) 1994-04-12
IL92537A0 (en) 1990-08-31
EP0376534A1 (en) 1990-07-04
CA2004597A1 (en) 1990-06-15
KR900009084A (ko) 1990-07-02
NL980042I1 (nl) 1999-02-01
DK176121B1 (da) 2006-09-11
DE19975026I2 (de) 2010-07-08
ES2062043T3 (es) 1994-12-16
ZA899450B (en) 1990-09-26
IE62569B1 (en) 1995-02-08
CA2004597C (en) 2000-02-08
DK613889A (da) 1990-06-16
KR0150445B1 (ko) 1998-10-15
NZ231655A (en) 1992-06-25
EP0376534B1 (en) 1993-12-15
JP2915034B2 (ja) 1999-07-05
HK1006275A1 (en) 1999-02-19
AU631585B2 (en) 1992-12-03
AU4670689A (en) 1990-06-21
IE893888L (en) 1990-06-15
DE68911499D1 (de) 1994-01-27
DE68911499T2 (de) 1994-06-30
JPH02282327A (ja) 1990-11-19

Similar Documents

Publication Publication Date Title
DK613889D0 (da) Farmaceutisk praeparat indeholdende 1-isobutyl-1h-imidazo(4,5-c)quinolin-4-amin
IL84522A0 (en) Imidazopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
AU632099B2 (en) Olefinic 1h-imidazo (4,5-c)quinolin-4-amines
AU5005490A (en) 1h-imidazo(4,5-c)quinolin-4-amines
IT1213379B (it) Tiazolo [4,5-c]chinoline, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono.
ZA876817B (en) Imidazopyridine derivatives
ES2019646B3 (es) Procedimiento de preparacion de imidazopiridinas.
AU5149690A (en) Parenteral formulation of 1-isobutyl-1H-imidazo (4,5-c) quinolin-4-amine
DK195988D0 (da) Farmaceutisk praeparat indeholdende mikrokapsler
DK190986A (da) Imidazoquinolinonderivater
PH24909A (en) Imidazopyridine derivatives and pharmaceutical compositions
IL87809A0 (en) Imidazopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DK314089A (da) Orale praeparater
DK489189D0 (da) Farmaceutisk praeparat
DK440587A (da) Farmaceutisk praeparat indeholdende sulindac
DK47787A (da) Dihydropyridinderivatholdige retardpraeparater
DK603988D0 (da) Farmaceutisk praeparat
AT389119B (de) Pyrido(3,2,1-ij)-1,3,4-benzoxadiazinderivate und diese enthaltende pharmazeutische praeparate
IL96589A0 (en) 2-substituted-imidazo-(4,5-c)pyridines,their preparation,and pharmaceutical compositions containing them
MX5577A (es) Formulacion farmaceutica
DK336489A (da) Farmaceutisk praeparat
DK273187A (da) Farmaceutiske praeparater indeholdende naphthyridinderivater
DK624587D0 (da) Farmaceutisk praeparat indeholdende imidazolderivater
DK37589D0 (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
DK364589A (da) Pyrido(3,4-f)pyrrolo(1,2-b)(1,2,5)-triazepiner, deres fremstilling og anvendelse som laegemidler

Legal Events

Date Code Title Description
PUP Patent expired